Delivery Order SPE2DB22D1106-SPE2DB25FFHN7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,277 to Amerisourcebergen Drug Corporation to supply 1,000 tablets of 40mg pantoprazole sodium delayed release. The order is to be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 22, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,038.98 Firm Fixed Price Delivery Order is for the supply of 4,563,401,913 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Troop Support Medical awarded a $151,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of 40mg pantoprazole sodium delayed release. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The single day order runs from September 28 through 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will directly fulfill the contract without...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,688.38 for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of January 3, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,187,922 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The firm fixed-price contract, valued at $2,008.44, has an ultimate completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization, is the prime contractor with no major...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,841.28, is for the supply of 4,562,828,860 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a period of performance through November 16, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHN7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.98 for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg on September 8, 2025, with completion scheduled for September 9, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is being performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, delivering a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Pantoprazole, a proton pump inhibitor commonly used for gastric acid suppression in military medical settings, represents a routine pharmaceutical supply transaction under the company's established prime vendor relationship with DLA, demonstrating its ongoing capability to fulfill federal healthcare supply needs through competitive procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/8/25 |